Cargando…

Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma

Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogan, Berna, Erol, Muhammet Kazim, Toslak, Devrim, Coban, Deniz Turgut, Bulut, Mehmet, Cengiz, Ayse, Sari, Esin Sogutlu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425312/
https://www.ncbi.nlm.nih.gov/pubmed/25995641
http://dx.doi.org/10.2147/TCRM.S79232
_version_ 1782370469043765248
author Dogan, Berna
Erol, Muhammet Kazim
Toslak, Devrim
Coban, Deniz Turgut
Bulut, Mehmet
Cengiz, Ayse
Sari, Esin Sogutlu
author_facet Dogan, Berna
Erol, Muhammet Kazim
Toslak, Devrim
Coban, Deniz Turgut
Bulut, Mehmet
Cengiz, Ayse
Sari, Esin Sogutlu
author_sort Dogan, Berna
collection PubMed
description Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus examination revealed common flame-shaped hemorrhages, venous dilatation and tortuosity, Roth spots, serous macular detachment, and yellow macular deposits in both eyes. Evaluation with fundus fluorescein angiography, fundus autofluorescence, and spectral-domain optical coherence tomography resulted in suspicion of hyperviscosity retinopathy and referral to the hematology clinic. After hematology consultation confirmed a diagnosis of multiple myeloma, chemotherapy and plasmapheresis were initiated. Four months after presentation, best-corrected visual acuity was 20/20 in both eyes and improvement in hyperviscosity retinopathy, serous macular detachment, and yellow macular deposits was observed.
format Online
Article
Text
id pubmed-4425312
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44253122015-05-20 Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma Dogan, Berna Erol, Muhammet Kazim Toslak, Devrim Coban, Deniz Turgut Bulut, Mehmet Cengiz, Ayse Sari, Esin Sogutlu Ther Clin Risk Manag Case Report Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus examination revealed common flame-shaped hemorrhages, venous dilatation and tortuosity, Roth spots, serous macular detachment, and yellow macular deposits in both eyes. Evaluation with fundus fluorescein angiography, fundus autofluorescence, and spectral-domain optical coherence tomography resulted in suspicion of hyperviscosity retinopathy and referral to the hematology clinic. After hematology consultation confirmed a diagnosis of multiple myeloma, chemotherapy and plasmapheresis were initiated. Four months after presentation, best-corrected visual acuity was 20/20 in both eyes and improvement in hyperviscosity retinopathy, serous macular detachment, and yellow macular deposits was observed. Dove Medical Press 2015-04-30 /pmc/articles/PMC4425312/ /pubmed/25995641 http://dx.doi.org/10.2147/TCRM.S79232 Text en © 2015 Dogan et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
Dogan, Berna
Erol, Muhammet Kazim
Toslak, Devrim
Coban, Deniz Turgut
Bulut, Mehmet
Cengiz, Ayse
Sari, Esin Sogutlu
Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title_full Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title_fullStr Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title_full_unstemmed Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title_short Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
title_sort serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425312/
https://www.ncbi.nlm.nih.gov/pubmed/25995641
http://dx.doi.org/10.2147/TCRM.S79232
work_keys_str_mv AT doganberna serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT erolmuhammetkazim serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT toslakdevrim serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT cobandenizturgut serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT bulutmehmet serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT cengizayse serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma
AT sariesinsogutlu serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma